logoOmicsDI
  • Browse
  • Submit Data
  • Databases
  • API
  • Help

4 Results

Show all   Save search   Copy query

Show results for

  • UnknownUnknown (4)

Release Date

  • Previous page
  • 1 / 1
  • You're on page 1
  • Next page
Sort   by:  
Relevance
 Page size 
10
UnknownPhase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Long-term Safety and Clinical Activity in Patients with Conventional Chondrosarcoma.
Not available
S-EPMC12130799 | biostudies-literature
UnknownPhase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies.
Not available
S-EPMC6340722 | biostudies-literature
UnknownSafety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study.
Not available
S-EPMC7973128 | biostudies-literature
UnknownA double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence.
Not available
S-EPMC3914416 | biostudies-literature
  • Previous page
  • 1 / 1
  • You're on page 1
  • Next page
Sort   by:  
Relevance
 Page size 
10
OmicsDI is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

EMBL-EBI logoEMBL-EBI logo

OmicsDI Databases

  • PRIDE
  • PeptideAtlas
  • MassIVE
  • JPOST Repository
  • Physiome Model Repository
  • EGA
  • EVA
  • ENA
  • LINCS
  • PAXDB
  • Cell Collective
  • MetaboLights
  • Metabolomics Workbench
  • MetabolomeExpress
  • GNPS
  • BioModels
  • FAIRDOMHub
  • ArrayExpress
  • dbGaP
  • ExpressionAtlas
  • GEO
  • NODE

Information

  • Databases
  • Help
  • API
  • Contact us
  • Code on GitHub
  • Terms of use
  • Submit Data